发明名称 Inducible mutagenesis of target genes
摘要 The present invention relates generally to mutagenesis of target genes that takes advantage of the natural mutagenic capabilities of B cells, and enhances those capabilities by bringing the process of diversification under control. The invention provides a method for rapidly and inducibly generating point mutations and other types of diversification in expressed genes, such as antibody genes. This method can be coupled with selection to identify B cell clones that produce, for example, antibodies of high affinity or specificity. The diversification process can be modulated, accelerated, halted, switched between methods of mutagenesis and the like. The modulation of diversification in accordance with the invention is both inducible and reversible. The invention provides a means of rapid and feasible development of a repertoire of variant immunoglobulins and other polypeptides.
申请公布号 US2016201053(A1) 申请公布日期 2016.07.14
申请号 US201514998134 申请日期 2015.12.23
申请人 UNIVERSITY OF WASHINGTON 发明人 Maizels Nancy;Cummings W. Jason;Yabuki Munehisa
分类号 C12N15/10 主分类号 C12N15/10
代理机构 代理人
主权项 1. A method of producing B cells that produce an optimized polypeptide of interest, the method comprising: (a) culturing a B cell modified to reversibly induce accelerated diversification of a target gene containing a coding region of the polypeptide of interest in conditions that allow expression of the diversification factor, wherein said B cell expresses the polypeptide of interest on the surface of the B cell and wherein said B cell comprises: (i) a cis-regulatory element operably linked to the target gene, wherein the target gene comprises a promoter and a coding region; and(ii) a fusion construct that encodes a tethering factor fused to a diversification factor, wherein the tethering factor specifically binds to the cis-regulatory element of (a) and the diversification factor reversibly induces accelerated diversification of the coding region in the target gene; (b) selecting cells from the culture that bind a ligand that specifically binds the polypeptide of interest expressed on the B cell surface; and (c) repeating steps (a) and (b) until cells are selected that have a desired affinity for the ligand that specifically binds the polypeptide of interest.
地址 Seattle WA US